Inari Medical, Inc. (NARI) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
6001 Oak Canyon
Irvine, CA 92618
United States of America (the)
Phone
877 923 4747
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
1300
First IPO Date
May 22, 2020
| Name | Title | Pay | Year Born |
| Andrew J. Hykes | Chief Executive Officer, President & Director | 1.54M | 1973 |
| Kevin Strange | Chief Financial Officer | 864,633 | N/A |
| Thomas Tu | Chief Medical Officer | 865,633 | 1973 |
| Brian Strauss | Senior Vice President of Engineering | 0 | N/A |
| Eric Khairy | Senior Vice President of Marketing | 0 | N/A |
| Hussain Rangwala | Chief Technology Officer | 0 | N/A |
| John Hsu | Vice President of Investor Relations | 0 | N/A |
| Neil Bhalodkar | Vice President of Investor Relations | 0 | N/A |
| Tim Benner | Chief Commercial Officer | 0 | N/A |
| Angela Ahmad | General Counsel & Secretary | 0 | N/A |
| Karen Silva | Vice President of Finance & Accounting | 0 | N/A |
| Shannon Trevino | General Counsel & Corporate Secretary | 0 | N/A |
| Tara Dunn | Senior Vice President & GM of LimFlow | 0 | N/A |
| Paul A. Koehn | Senior Vice President of Operations | 0 | 1963 |
| Shon Chakrabarti | Chief Medical Officer of LimFlow | 0 | N/A |
Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.